G protein-coupled receptors (GPCRs) play an essential role in the regulation of many physiological processes, and they represent a major target for already validated as well as newly emerging drugs in ...
Certa Therapeutics Pty Ltd. has acquired Occurx Pty Ltd. in a move to strengthen its pipeline to target multiple fibrotic diseases as both companies share a focus on targeting GPR68, a defined G ...
Kaken will take the drug through phase I trials, after which J&J takes over. Under the terms, Kaken banks an up-front payment of $30 million and could collect more than $1.2 billion if development and ...
“Chronic abdominal pain is complex because it involves multiple mechanisms, including inflammation, altered gut motility, and heightened sensitivity of the nervous system,” Muttenhalter told IE. “The ...